Meeting
2015 ASCO Annual Meeting
Pancreatic metastases from renal cell carcinoma: Prognostic relevance and outcome in patients treated with targeted agents.
Authors
Paolo Grassi
Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Paolo Grassi , Ludovic S. Doucet , Palma Giglione , Viktor Gruenwald , Bohuslav Melichar , Luca Galli , Ugo De Giorgi , Annalisa Guida , Cinzia Ortega , Matteo Santoni , Aristotelis Bamias , Elena Verzoni , Andrea Necchi , Lisa Derosa , Hana Studentova , Monica Pacifici , Filippo G. De Braud , Camillo Porta , Bernard J. Escudier , Giuseppe Procopio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Kidney Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4550)
DOI
10.1200/jco.2015.33.15_suppl.4550
Abstract #
4550
Poster Bd #
223
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Prognosis and outcome of patients with pancreatic metastases from renal cell carcinoma: When the site matters.
First Author: Paolo Grassi
Poster
2014 ASCO Quality Care Symposium
Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.
First Author: Lori Wood
Poster
2022 ASCO Genitourinary Cancers Symposium
Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma.
First Author: Xieqiao Yan
Poster
2020 Genitourinary Cancers Symposium
Progression-free survival (PFS) and overall survival (OS) across ethnicities for patients with metastatic renal cell carcinoma (mRCC) receiving targeted therapies (TT) as first-line (1L) treatment.
First Author: Nicholas Salgia